OrbiMed Advisors LLC's Form 4 filing
Passage BIO, Inc. (PASG) · filed Jun 26, 2025
- Accession no.
- 0000947871-25-000629
- Filed
- Jun 26, 2025, 5:10 PM ET
- Trade date
- Jun 24-26, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $197.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | 10% Owner |
| OrbiMed Capital GP VII LLCCIK 0001760648 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2025 | Common Stock | SSaleDisposed | −231,600 | $0.35 | −$81,060 | 6,418,400 | Indirect | |
| Jun 25, 2025 | Common Stock | SSaleDisposed | −138,800 | $0.33 | −$45,804 | 6,279,600 | Indirect | |
| Jun 26, 2025 | Common Stock | SSaleDisposed | −213,257 | $0.33 | −$70,374.81 | 6,066,343 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.